Clinchoice Enterprise Management Shanghai
Clinchoice Enterprise Management Shanghai is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of ABSK021 to Assess the Efficacy and Safety in Patients with Tenosynovial Giant Cell Tumor
Sponsor Abbisko Therapeutics Co. Ltd.
- Start (EU)
- Latest update
- Estimated end
A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor BeOne Medicines AG
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Clinchoice Enterprise Management Shanghai?
The 2026-10-09 snapshot links Clinchoice Enterprise Management Shanghai to 2 distinct CTIS trials. Recorded services include IDMC vendor, Medical expertise. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Clinchoice Enterprise Management Shanghai?
The most frequently recorded therapeutic areas are Musculoskeletal, Solid Tumor Oncology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Clinchoice Enterprise Management Shanghai conducted?
The linked trials record locations in 12 countries, including Spain, France, Italy, Netherlands, Poland. These are trial locations, not confirmed office locations or countries where Clinchoice Enterprise Management Shanghai delivered services.
What can this page tell me about Clinchoice Enterprise Management Shanghai's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Clinchoice Enterprise Management Shanghai. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Clinchoice Enterprise Management Shanghai Limited